These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 29472858)
1. An Integrated Lipidomics and Phenotype Study Reveals Protective Effect and Biochemical Mechanism of Traditionally Used Dou F; Miao H; Wang JW; Chen L; Wang M; Chen H; Wen AD; Zhao YY Front Pharmacol; 2018; 9():53. PubMed ID: 29472858 [No Abstract] [Full Text] [Related]
2. The link between phenotype and fatty acid metabolism in advanced chronic kidney disease. Chen DQ; Chen H; Chen L; Vaziri ND; Wang M; Li XR; Zhao YY Nephrol Dial Transplant; 2017 Jul; 32(7):1154-1166. PubMed ID: 28339984 [TBL] [Abstract][Full Text] [Related]
3. Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism. Chen H; Chen L; Liu D; Chen DQ; Vaziri ND; Yu XY; Zhang L; Su W; Bai X; Zhao YY J Proteome Res; 2017 Apr; 16(4):1566-1578. PubMed ID: 28286957 [TBL] [Abstract][Full Text] [Related]
4. Bupi Yishen formula may prevent kidney fibrosis by modulating fatty acid metabolism in renal tubules. Liu B; Jie X; Deng J; Zhang S; Lu F; Liu X; Zhang D Phytomedicine; 2023 Jun; 114():154767. PubMed ID: 37001297 [TBL] [Abstract][Full Text] [Related]
5. Wang YN; Wu XQ; Zhang DD; Hu HH; Liu JL; Vaziri ND; Guo Y; Zhao YY; Miao H Front Pharmacol; 2021; 12():633566. PubMed ID: 33679418 [No Abstract] [Full Text] [Related]
6. An integrated approach to uncover quality marker underlying the effects of Alisma orientale on lipid metabolism, using chemical analysis and network pharmacology. Liao M; Shang H; Li Y; Li T; Wang M; Zheng Y; Hou W; Liu C Phytomedicine; 2018 Jun; 45():93-104. PubMed ID: 29705003 [TBL] [Abstract][Full Text] [Related]
7. Protective effects of Salvia miltiorrhiza on adenine-induced chronic renal failure by regulating the metabolic profiling and modulating the NADPH oxidase/ROS/ERK and TGF-β/Smad signaling pathways. Cai H; Su S; Li Y; Zeng H; Zhu Z; Guo J; Zhu Y; Guo S; Yu L; Qian D; Tang Y; Duan J J Ethnopharmacol; 2018 Feb; 212():153-165. PubMed ID: 29032117 [TBL] [Abstract][Full Text] [Related]
8. Lipidomics reveals the potential mechanism of honokiol against adenine-induced chronic kidney disease. Liu X; Gao L; Huang X; Deng R; Wei X; Lu J; Li S Front Pharmacol; 2022; 13():1019629. PubMed ID: 36313325 [TBL] [Abstract][Full Text] [Related]
9. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease]. Banković-Calić N; Ogbori MR; Nicman E Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic Effects of Wu Y; Wang X; Yang L; Kang S; Yan G; Han Y; Fang H; Sun H Am J Chin Med; 2023; 51(3):623-650. PubMed ID: 36961296 [TBL] [Abstract][Full Text] [Related]
11. Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice. Santana AC; Degaspari S; Catanozi S; Dellê H; de Sá Lima L; Silva C; Blanco P; Solez K; Scavone C; Noronha IL Nephrol Dial Transplant; 2013 May; 28(5):1140-9. PubMed ID: 23345625 [TBL] [Abstract][Full Text] [Related]
12. Activated NF-κB/Nrf2 and Wnt/β-catenin pathways are associated with lipid metabolism in CKD patients with microalbuminuria and macroalbuminuria. Feng YL; Chen H; Chen DQ; Vaziri ND; Su W; Ma SX; Shang YQ; Mao JR; Yu XY; Zhang L; Guo Y; Zhao YY Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2317-2332. PubMed ID: 31102786 [TBL] [Abstract][Full Text] [Related]
13. Diuretic and anti-diuretic activities of fractions of Alismatis rhizoma. Chen DQ; Feng YL; Tian T; Chen H; Yin L; Zhao YY; Lin RC J Ethnopharmacol; 2014 Nov; 157():114-8. PubMed ID: 25256686 [TBL] [Abstract][Full Text] [Related]
14. Biomarker identification and pathway analysis of Lu L; Lu J; Chen J; Wang B; Peng H; Peng J; Liu X; Lin F; Xiong G Front Pharmacol; 2023; 14():1103527. PubMed ID: 37089928 [No Abstract] [Full Text] [Related]
15. Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression. Chen H; Cao G; Chen DQ; Wang M; Vaziri ND; Zhang ZH; Mao JR; Bai X; Zhao YY Redox Biol; 2016 Dec; 10():168-178. PubMed ID: 27750081 [TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats. Wang DT; Huang RH; Cheng X; Zhang ZH; Yang YJ; Lin X Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602 [TBL] [Abstract][Full Text] [Related]
17. Protective Effects of Alisma orientale Extract against Hepatic Steatosis via Inhibition of Endoplasmic Reticulum Stress. Jang MK; Han YR; Nam JS; Han CW; Kim BJ; Jeong HS; Ha KT; Jung MH Int J Mol Sci; 2015 Nov; 16(11):26151-65. PubMed ID: 26540043 [TBL] [Abstract][Full Text] [Related]
18. Lipid Accumulation and Chronic Kidney Disease. Gai Z; Wang T; Visentin M; Kullak-Ublick GA; Fu X; Wang Z Nutrients; 2019 Mar; 11(4):. PubMed ID: 30925738 [TBL] [Abstract][Full Text] [Related]
19. Huangqi-Danshen Decoction Ameliorates Adenine-Induced Chronic Kidney Disease by Modulating Mitochondrial Dynamics. Liu X; Huang S; Wang F; Zheng L; Lu J; Chen J; Li S Evid Based Complement Alternat Med; 2019; 2019():9574045. PubMed ID: 30713579 [TBL] [Abstract][Full Text] [Related]
20. Over-expressed microRNA-181a reduces glomerular sclerosis and renal tubular epithelial injury in rats with chronic kidney disease via down-regulation of the TLR/NF-κB pathway by binding to CRY1. Liu L; Pang XL; Shang WJ; Xie HC; Wang JX; Feng GW Mol Med; 2018 Sep; 24(1):49. PubMed ID: 30241461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]